GSCLX
Price
$26.93
Change
+$0.24 (+0.90%)
Updated
May 8 closing price
Net Assets
1.36B
RGABX
Price
$64.63
Change
+$0.47 (+0.73%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

GSCLX vs RGABX

Header iconGSCLX vs RGABX Comparison
Open Charts GSCLX vs RGABXBanner chart's image
Goldman Sachs Large Cap Gr Insghts Svc
Price$26.93
Change+$0.24 (+0.90%)
VolumeN/A
Net Assets1.36B
American Funds Growth Fund of Amer R2
Price$64.63
Change+$0.47 (+0.73%)
VolumeN/A
Net Assets283.8B
GSCLX vs RGABX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSCLX vs. RGABX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSCLX is a StrongBuy and RGABX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 284B vs. GSCLX (1.36B). GSCLX (0.00) and RGABX (0.00) have matching dividends . GSCLX was incepted earlier than RGABX: GSCLX (28 years) vs RGABX (23 years). RGABX (1.39) is less costly to investors than GSCLX (1.09). GSCLX is a more actively managed with annual turnover of: 215.00 vs. RGABX (25.00). GSCLX has a lower initial minimum investment than RGABX: GSCLX (0) vs RGABX (250). RGABX annual gain was more profitable for investors over the last year : 1.96 vs. GSCLX (-3.38). RGABX return over 5 years is better than : 36.12 vs. GSCLX (-15.31).
GSCLXRGABXGSCLX / RGABX
Total Expense Ratio1.061.3976%
Annual Report Gross Expense Ratio1.091.3978%
Fund Existence28 years23 years-
Gain YTD-9.490-2.695352%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.36B284B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.381.96-173%
Returns for 3 years2.1029.217%
Returns for 5 years-15.3136.12-42%
Returns for 10 years18.0148.3737%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS8.600.12
+1.42%
Viatris
FDMT3.120.04
+1.14%
4D Molecular Therapeutics
ICFI84.38-0.08
-0.09%
ICF International
AIMD0.54N/A
-0.19%
Ainos
NAGE8.45-0.28
-3.21%
Niagen Bioscience Inc